Restriction of virus infection but not catalytic dntpase activity is regulated by phosphorylation of samhd1

Journal of Virology

Volumn 87, Issue 21, 2013, Pages 11516-11524

  Welbourn, Sarah ^a   Dutta, Sucharita M ^b   Semmes, John ^b   Strebela, Klaus ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; DEOXYNUCLEOSIDE TRIPHOSPHOHYDROLASE; GLUTAMIC ACID; NUCLEOSIDE TRIPHOSPHATASE; PHOSPHOPROTEIN; PHOSPHORUS 32; STERILE ALPHA MOTIF AND HD DOMAIN PROTEIN 1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIVIRAL ACTIVITY; ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; GENE; GENE FUNCTION; GENE LOCATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOBLOTTING; IN VITRO STUDY; ISOTOPE LABELING; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; SAMHD1 GENE; VIRUS CELL INTERACTION;

CELL LINE; DNA MUTATIONAL ANALYSIS; HIV-1; HUMANS; IMMUNOBLOTTING; ISOTOPE LABELING; MASS SPECTROMETRY; MONOMERIC GTP-BINDING PROTEINS; MUTAGENESIS, SITE-DIRECTED; NUCLEOSIDE-TRIPHOSPHATASE; PHOSPHORUS RADIOISOTOPES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84886932687     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01642-13     Document Type: Article

References (36)

1. Strebel K, Luban J, Jeang KT. 2009. Human cellular restriction factors that target HIV-1 replication. BMC Med. 7:48. doi:10.1186/1741-7015-7-48.
2. Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, Segeral E, Yatim A, Emiliani S, Schwartz O, Benkirane M. 2011. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474:654-657.
3. Hrecka K, Hao C, Gierszewska M, Swanson SK, Kesik-Brodacka M, Srivastava S, Florens L, Washburn MP, Skowronski J. 2011. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474:658-661.
4. Berger A, Sommer AF, Zwarg J, Hamdorf M, Welzel K, Esly N, Panitz S, Reuter A, Ramos I, Jatiani A, Mulder LC, Fernandez-Sesma A, Rutsch F, Simon V, Konig R, Flory E. 2011. SAMHD1-deficient CD14 cells from individuals with Aicardi-Goutieres syndrome are highly susceptible to HIV-1 infection. PLoS Pathog. 7:e1002425. doi:10.1371/journal.ppat.1002425.
5. Goujon C, ArfiV, Pertel T, Luban J, Lienard J, Rigal D, Darlix JL, Cimarelli A. 2008. Characterization of simian immunodeficiency virus SIVSM/human immunodeficiency virus type 2 Vpx function in human myeloid cells. J. Virol. 82:12335-12345.
6. Goujon C, Riviere L, Jarrosson-Wuilleme L, Bernaud J, Rigal D, Darlix J-L, Cimarelli A. 2007. SIVSM/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells. Retrovirology. 4:2.
7. Sharova N, Wu Y, Zhu X, Stranska R, Kaushik R, Sharkey M, Stevenson M. 2008. Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction. PLoS Pathog. 4:e1000057. doi:10.1371/journal.ppat.1000057.
8. Gramberg T, Sunseri N, Landau NR. 2010. Evidence for an activation domain at the amino terminus of simian immunodeficiency virus Vpx. J. Virol. 84:1387-1396.
9. Baldauf H-M, Pan X, Erikson E, Schmidt S, Daddacha W, Burggraf M, Schenkova K, Ambiel I, Wabnitz G, Gramberg T, Panitz S, Flory E, Landau NR, Sertel S, Rutsch F, Lasitschka F, Kim B, Konig R, Fackler OT, Keppler OT. 2012. SAMHD1 restricts HIV-1 infection in resting CD4 T cells. Nat. Med. 18:1682-1687.
10. Descours B, Cribier A, Chable-Bessia C, Ayinde D, Rice G, Crow Y, Yatim A, Schwartz O, Laguette N, Benkirane M. 2012. SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4 T cells. Retrovirology 9:87.
11. Ahn J, Hao C, Yan J, Delucia M, Mehrens J, Wang C, Gronenborn AM, Skowronski J. 2012. HIV/simian immunodeficiency virus (SIV) accessory virulence factor Vpx loads the host cell restriction factor SAMHD1 onto the E3 ubiquitin ligase complex CRL4DCAF1. J. Biol. Chem. 287:12550-12558.
12. Rice GI, Bond J, Asipu A, Brunette RL, Manfield IW, Carr IM, Fuller JC, Jackson RM, Lamb T, Briggs TA, Ali M, Gornall H, Couthard LR, Aeby A, Attard-Montalto SP, Bertini E, Bodemer C, Brockmann K, Brueton LA, Corry PC, Desguerre I, Fazzi E, Cazorla AG, Gener B, Hamel BCJ, Heiberg A, Hunter M, van der Knaap MS, Kumar R, Lagae L, Landrieu PG, Lourenco CM, Marom D, McDermott MF, van der Merwe W, Orcesi S, Prendiville JS, Rasmussen M, Shalev SA, Soler DM, Shinawi M, Spiegel R, Tan TY, Vanderver A, Wakeling EL, Wassmer E, Whittaker E, Lebon P, Stetson DB, Bonthron DT, Crow YJ. 2009. Mutations involved in Aicardi-Goutieres syndrome implicate SAMHD1 as regulator of the innate immune response. Nat. Genet. 41:829-832.
13. Dussaix E, Lebon P, Ponsot G, Huault G, Tardieu M. 1985. Intrathecal synthesis of different alpha-interferons in patients with various neurological diseases. Acta Neurol. Scand. 71:504-509.
14. Lee-Kirsch MA. 2010. Nucleic acid metabolism and systemic autoimmunity revisited. Arthritis Rheum. 62:1208-1212.
15. White TE, Brandariz-Nunez A, Carlos Valle-Casuso J, Amie S, Nguyen L, Kim B, Brojatsch J, Diaz-Griffero F. 2013. Contribution of SAM and HD domains to retroviral restriction mediated by human SAMHD1. Virology 436:81-90.
16. Goncalves A, Karayel E, Rice GI, Bennett KL, Crow YJ, Superti-Furga G, Burckstummer T. 2012. SAMHD1 is a nucleic-acid binding protein that is mislocalized due to Aicardi-Goutieres syndrome-associated mutations. Hum. Mutat. 33:1116-1122.
17. Beloglazova N, Flick R, Tchigvintsev A, Brown G, Popovic A, Nocek B, Yakunin AF. 2013. Nuclease activity of the human SAMHD1 protein implicated in the Aicardi-Goutieres syndrome and HIV-1 restriction. J. Biol. Chem. 288:8101-8110.
18. Tungler V, Staroske W, Kind B, Dobrick M, Kretschmer S, Schmidt F, Krug C, Lorenz M, Chara O, Schwille P, Lee-Kirsch MA. 2013. Singlestranded nucleic acids promote SAMHD1 complex formation. J. Mol. Med. (Berl.) 91:759-770.
19. Goldstone DC, Ennis-Adeniran V, Hedden JJ, Groom HC, Rice GI, Christodoulou E, Walker PA, Kelly G, Haire LF, Yap MW, de CarvalhoLP, Stoye JP, Crow YJ, Taylor IA, Webb M. 2011. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 480:379-382.
20. Powell RD, Holland PJ, Hollis T, Perrino FW. 2011. Aicardi-Goutieres syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTPregulated deoxynucleotide triphosphohydrolase. J. Biol. Chem. 286: 43596-43600.
21. Lahouassa H, Daddacha W, Hofmann H, Ayinde D, Logue EC, Dragin L, Bloch N, Maudet C, Bertrand M, Gramberg T, Pancino G, Priet S, Canard B, Laguette N, Benkirane M, Transy C, Landau NR, Kim B, Margottin-Goguet F. 2012. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat. Immunol. 13:223-228.
22. Kim B, Nguyen LA, Daddacha W, Hollenbaugh JA. 2012. Tight interplay among SAMHD1 protein level, cellular dNTP levels, and HIV-1 proviral DNA synthesis kinetics in human primary monocyte-derived macrophages. J. Biol. Chem. 287:21570-21574.
23. St Gelais C, de Silva S, Amie SM, Coleman CM, Hoy H, Hollenbaugh JA, Kim B, Wu L. 2012. SAMHD1 restricts HIV-1 infection in dendritic cells (DCs) by dNTP depletion, but its expression in DCs and primary CD4 T-lymphocytes cannot be upregulated by interferons. Retrovirology 9:105.
24. Welbourn S, Miyagi E, White TE, Diaz-Griffero F, Strebel K. 2012. Identification and characterization of naturally occurring splice variants of SAMHD1. Retrovirology 9:86.
25. Bern M, Cai Y, Goldberg D. 2007. Lookup peaks: a hybrid of de novo sequencing and database search for protein identification by tandem mass spectrometry. Anal. Chem. 79:1393-1400.
26. Cross TG, Scheel-Toellner D, Henriquez NV, Deacon E, Salmon M, Lord JM. 2000. Serine/threonine protein kinases and apoptosis. Exp. Cell Res. 256:34-41.
27. Ayinde D, Casartelli N, Schwartz O. 2012. Restricting HIV the SAMHD1 way: through nucleotide starvation. Nat. Rev. Microbiol. 10:675-680.
28. Amie SM, Noble E, Kim B. 2013. Intracellular nucleotide levels and the control of retroviral infections. Virology 436:247-254.
29. Li N, Zhang W, Cao X. 2000. Identification of human homologue of mouse IFN-gamma induced protein from human dendritic cells. Immunol. Lett. 74:221-224.
30. Dragin L, Nguyen LA, Lahouassa H, Sourisce A, Kim B, Ramirez BC, Margottin-Goguet F. 2013. Interferon block to HIV-1 transduction in macrophages despite SAMHD1 degradation and high deoxynucleoside triphosphates supply. Retrovirology 10:30.
31. Goujon C, Schaller T, Galao RP, Amie SM, Kim B, Olivieri K, Neil SJD, Malim MH. 2013. Evidence for IFN-induced, SAMHD1-independent inhibitors of early HIV-1 infection. Retrovirology 10:23.
32. Endicott JA, Noble ME, Tucker JA. 1999. Cyclin-dependent kinases: inhibition and substrate recognition. Curr. Opin. Struct. Biol. 9:738-744.
33. Nigg EA. 1993. Cellular substrates of p34(cdc2) and its companion cyclindependent kinases. Trends Cell Biol. 3:296-301.
34. Yan J, Kaur S, Delucia M, Hao C, Mehrens J, Wang C, Golczak M, Palczewski K, Gronenborn AM, Ahn J, Skowronski J. 2013. Tetramerization of SAMHD1 is required for biological activity and inhibition of HIV infection. J. Biol. Chem. 288:10406-10417.
35. White TE, Brandariz-Nunez A, Valle-Casuso JC, Amie S, Nguyen LA, Kim B, Tuzova M, Diaz-Griffero F. 2013. The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation. Cell Host Microbe 13:441-451.
36. Cribier A, Descours B, Valadao ALC, Laguette N, Benkirane M. 2013. Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV-1. Cell Rep. 3:1036-1043.